Stock Scorecard
Stock Summary for Exact Sciences Corp (EXAS) - $54.49 as of 11/20/2024 4:02:12 PM EST
Total Score
6 out of 30
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for EXAS
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for EXAS
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for EXAS
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for EXAS
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for EXAS (45 out of 90)
Stock Price Rating (Max of 10) | 9 |
Historical Stock Price Rating (Max of 10) | 10 |
Stock Price Trend (Max of 10) | 1 |
Book Value (Max of 10) | 6 |
Book Value to Price (Max of 10) | 0 |
Analyst Buy Ratings (Max of 5) | 5 |
Analyst Strong Buy Ratings (Max of 5) | 4 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 0 |
Trading Volume (Max of 10) | 10 |
Price to Earnings (Max of 10) | 0 |
Latest News for for EXAS
Financial Details for EXAS
Company Overview |
|
---|---|
Ticker | EXAS |
Company Name | Exact Sciences Corp |
Country | USA |
Description | Exact Sciences Corporation offers cancer screening and diagnostic test products in the United States and internationally. The company is headquartered in Madison, Wisconsin. |
Sector Name | TRADE & SERVICES |
Industry Name | SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH |
Most Recent Quarter | 9/30/2024 |
Next Earnings Date | N/A |
Stock Price History |
|
Last Day Price | 54.49 |
Price 4 Years Ago | 132.49 |
Last Day Price Updated | 11/20/2024 4:02:12 PM EST |
Last Day Volume | 2,134,822 |
Average Daily Volume | 2,714,733 |
52-Week High | 79.62 |
52-Week Low | 40.62 |
Last Price to 52 Week Low | 34.15% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 122.49 |
Sector PE | 41.04 |
5-Year Average PE | -41.71 |
Free Cash Flow Ratio | 9.87 |
Industry Free Cash Flow Ratio | 30.25 |
Sector Free Cash Flow Ratio | 94.88 |
Current Ratio Most Recent Quarter | 2.12 |
Total Cash Per Share | 5.52 |
Book Value Per Share Most Recent Quarter | 17.35 |
Price to Book Ratio | 3.11 |
Industry Price to Book Ratio | 5.37 |
Sector Price to Book Ratio | 9.15 |
Price to Sales Ratio Twelve Trailing Months | 3.62 |
Industry Price to Sales Ratio Twelve Trailing Months | 10.17 |
Sector Price to Sales Ratio Twelve Trailing Months | 2.18 |
Analyst Buy Ratings | 17 |
Analyst Strong Buy Ratings | 3 |
Share Statistics |
|
Total Shares Outstanding | 185,076,000 |
Market Capitalization | 10,084,791,240 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Total Years Dividend Increasing | N/A |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 2.09% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | 67.26% |
Reported EPS 12 Trailing Months | -1.16 |
Reported EPS Past Year | -0.90 |
Reported EPS Prior Year | -1.14 |
Net Income Twelve Trailing Months | -214,038,000 |
Net Income Past Year | -204,149,000 |
Net Income Prior Year | -623,506,000 |
Quarterly Revenue Growth YOY | 12.80% |
5-Year Revenue Growth | 61.58% |
Operating Margin Twelve Trailing Months | -0.03 |
Balance Sheet |
|
Total Cash Most Recent Quarter | 1,021,131,000 |
Total Cash Past Year | 777,644,000 |
Total Cash Prior Year | 632,057,000 |
Net Cash Position Most Recent Quarter | -1,547,397,000 |
Net Cash Position Past Year | -1,586,632,000 |
Long Term Debt Past Year | 2,364,276,000 |
Long Term Debt Prior Year | 2,236,106,000 |
Total Debt Most Recent Quarter | 2,568,528,000 |
Equity to Debt Ratio Past Year | 0.57 |
Equity to Debt Ratio Most Recent Quarter | 0.56 |
Total Stockholder Equity Past Year | 3,145,305,000 |
Total Stockholder Equity Prior Year | 3,043,162,000 |
Total Stockholder Equity Most Recent Quarter | 3,210,511,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | 53,427,000 |
Free Cash Flow Per Share Twelve Trailing Months | 0.29 |
Free Cash Flow Past Year | 31,929,000 |
Free Cash Flow Prior Year | -438,021,000 |
Options |
|
Put/Call Ratio | 0.19 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -5.02 |
MACD Signal | -3.36 |
20-Day Bollinger Lower Band | 41.98 |
20-Day Bollinger Middle Band | 59.71 |
20-Day Bollinger Upper Band | 77.43 |
Beta | 1.27 |
RSI | 21.09 |
50-Day SMA | 59.51 |
150-Day SMA | 61.32 |
200-Day SMA | 73.77 |
System |
|
Modified | 11/21/2024 12:27:05 AM EST |